Tweet / Twitter
Don’t miss what’s happeningPeople on Twitter are the first to know.
Don’t miss what’s happeningPeople on Twitter are the first to know.
AbstractBackground/Aims. To identify the risk of serious infections (SI) according to initial treatment strategy, using conventional synthetic disease modi
FDA is alerting health care professionals of the rare risk of intrahepatic cholestasis of pregnancy (ICP) associated with the use of thiopurines.
The British Society for Rheumatology and the British Association of Dermatologists developed guidelines for the management of people living with Behçet’s disease.
Spondyloarthritis Faculty Panel Q&A – featuring Drs. Eric Ruderman, Lihi Eder, and Lianne Gensler; moderated by Dr. Artie Kavanaugh
Machine learning (ML) models were applied to 3 cohorts of lupus nephritis (LN) patients and established algorithms to predict co-infection in LN. This study analyzed 111…
Throughout April, join us for session highlights from RheumNow Live 2024. During each Tuesday Night Rheumatology webinar, highlights from three select sessions will be replayed,…
An observational cohort study suggests that proteinuria levels in lupus nephritis (LN) patients did not predict their histologic class. A multicentre observational study of patients…
Clinical Rheumatology – To evaluate the association between enthesitis resolution (ER) and dactylitis resolution (DR) and meaningful improvements in patient-reported outcomes (PROs) among…
AbstractObjectives. To assess the frequency and characteristics of severe relapse in patients with GCA in a real-life setting.Methods. In a monocentric dat
The 50th biosimilar approval milestone also reflects our strategic approach to biosimilars, as outlined in the FDA’s Biosimilars Action Plan.